Effect of 28 consecutive days lymphoblastoid interferon (α-IFN) administration on hepatitis B virus related chronic liver disease
- 1 January 1986
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 3, S239-S243
- https://doi.org/10.1016/s0168-8278(86)80127-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Recombinant Leukocyte Interferon Treatment of Chronic Hepatitis BHepatology, 1985
- Natural History of Chronic Hepatitis B Virus Infection in Taiwan: Studies of Hepatitis B Virus Dna in SerumHepatology, 1985
- Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replicationLiver International, 1984
- Detection of Hepatitis B Virus DNA in Serum by a Simple Spot Hybridization Technique: Comparison with Results for Other Viral MarkersHepatology, 1983
- Immunoregulatory T cells in HBV-induced chronic liver disease as defined by monoclonal antibodiesClinical Immunology and Immunopathology, 1983
- Spontaneous Disappearance of Viral Replication and Liver Cell Inflammation in Hbsag–Positive Chronic Active Hepatitis: Results of A Placebo Vs. Interferon TrialHepatology, 1982
- Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferonJournal of Clinical Immunology, 1981
- Recycling and target binding capacity of human natural killer cells.The Journal of Experimental Medicine, 1981
- Augmentation of human monocyte-mediated cytolysis by interferonCellular Immunology, 1980
- Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1977